Logo image of BLE

BLACKROCK MUNI INC TR II (BLE) Stock Price, Quote, News and Overview

NYSE:BLE - New York Stock Exchange, Inc. - US09249N1019 - Currency: USD

10.035  +0.07 (+0.75%)

Fundamental Rating

2

Taking everything into account, BLE scores 2 out of 10 in our fundamental rating. BLE was compared to 0 industry peers in the Unkown industry. BLE may be in some trouble as it scores bad on both profitability and health. BLE does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

BLE had positive earnings in the past year.
In the past year BLE had a positive cash flow from operations.
BLE had positive earnings in 4 of the past 5 years.
In the past 5 years BLE always reported a positive cash flow from operatings.
BLE Yearly Net Income VS EBIT VS OCF VS FCFBLE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M 100M

1.2 Ratios

Industry RankSector Rank
ROA -0.32%
ROE -0.51%
ROIC 1.85%
ROA(3y)1.37%
ROA(5y)2.02%
ROE(3y)2.25%
ROE(5y)3.28%
ROIC(3y)1.92%
ROIC(5y)2.12%
BLE Yearly ROA, ROE, ROICBLE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2 4 6 8 10

1.3 Margins

BLE's Operating Margin has declined in the last couple of years.
In the last couple of years the Gross Margin of BLE has declined.
Industry RankSector Rank
OM 52.2%
PM (TTM) N/A
GM 52.9%
OM growth 3Y-7.35%
OM growth 5Y-6.49%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.47%
GM growth 5Y-6.54%
BLE Yearly Profit, Operating, Gross MarginsBLE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 100 150

More info and screens

2

2. Health

2.1 Basic Checks

The number of shares outstanding for BLE has been reduced compared to 1 year ago.
BLE has more shares outstanding than it did 5 years ago.
BLE has a better debt/assets ratio than last year.
BLE Yearly Shares OutstandingBLE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
BLE Yearly Total Debt VS Total AssetsBLE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

BLE has an Altman-Z score of 0.80. This is a bad value and indicates that BLE is not financially healthy and even has some risk of bankruptcy.
The Debt to FCF ratio of BLE is 3.15, which is a good value as it means it would take BLE, 3.15 years of fcf income to pay off all of its debts.
BLE has a Debt/Equity ratio of 0.58. This is a neutral value indicating BLE is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 3.15
Altman-Z 0.8
ROIC/WACCN/A
WACCN/A
BLE Yearly LT Debt VS Equity VS FCFBLE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.3 Liquidity

A Current Ratio of 0.04 indicates that BLE may have some problems paying its short term obligations.
A Quick Ratio of 0.04 indicates that BLE may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.04
Quick Ratio 0.04
BLE Yearly Current Assets VS Current LiabilitesBLE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

More info and screens

2

3. Growth

3.1 Past

BLE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -32.84%.
The Revenue has been growing slightly by 0.10% in the past year.
BLE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.23% yearly.
EPS 1Y (TTM)-32.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%648.5%
Revenue 1Y (TTM)0.1%
Revenue growth 3Y17.71%
Revenue growth 5Y9.23%
Sales Q2Q%-5.36%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BLE Yearly Revenue VS EstimatesBLE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 30.41, which means the current valuation is very expensive for BLE.
BLE's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.98.
Industry RankSector Rank
PE 30.41
Fwd PE N/A
BLE Price Earnings VS Forward Price EarningsBLE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 4.48
EV/EBITDA N/A
BLE Per share dataBLE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.87%, BLE is a good candidate for dividend investing.
BLE's Dividend Yield is rather good when compared to the S&P500 average which is at 2.46.
Industry RankSector Rank
Dividend Yield 5.87%

5.2 History

The dividend of BLE decreases each year by -7.79%.
BLE has paid a dividend for at least 10 years, which is a reliable track record.
BLE has decreased its dividend recently.
Dividend Growth(5Y)-7.79%
Div Incr Years1
Div Non Decr Years1
BLE Yearly Dividends per shareBLE Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

BLE has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-864.41%
EPS Next 2YN/A
EPS Next 3YN/A
BLE Yearly Income VS Free CF VS DividendBLE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M 100M

More info and screens

BLACKROCK MUNI INC TR II

NYSE:BLE (4/30/2025, 3:38:53 PM)

10.035

+0.07 (+0.75%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners34.24%
Inst Owner Change0.52%
Ins OwnersN/A
Ins Owner Change0.05%
Market Cap478.97M
Analysts0
Price TargetN/A
Short Float %0.05%
Short Ratio0.19
Dividend
Industry RankSector Rank
Dividend Yield 5.87%
Yearly Dividend0.52
Dividend Growth(5Y)-7.79%
DP-864.41%
Div Incr Years1
Div Non Decr Years1
Ex-Date04-15 2025-04-15 (0.054)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 30.41
Fwd PE N/A
P/S 11.57
P/FCF 4.48
P/OCF 4.48
P/B 0.82
P/tB 0.82
EV/EBITDA N/A
EPS(TTM)0.33
EY3.29%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)2.24
FCFY22.3%
OCF(TTM)2.24
OCFY22.3%
SpS0.87
BVpS12.23
TBVpS12.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.32%
ROE -0.51%
ROCE 2.35%
ROIC 1.85%
ROICexc 1.86%
ROICexgc 1.86%
OM 52.2%
PM (TTM) N/A
GM 52.9%
FCFM 258.1%
ROA(3y)1.37%
ROA(5y)2.02%
ROE(3y)2.25%
ROE(5y)3.28%
ROIC(3y)1.92%
ROIC(5y)2.12%
ROICexc(3y)1.92%
ROICexc(5y)2.12%
ROICexgc(3y)1.92%
ROICexgc(5y)2.12%
ROCE(3y)2.43%
ROCE(5y)2.68%
ROICexcg growth 3Y-7.17%
ROICexcg growth 5Y-6.88%
ROICexc growth 3Y-7.17%
ROICexc growth 5Y-6.88%
OM growth 3Y-7.35%
OM growth 5Y-6.49%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.47%
GM growth 5Y-6.54%
F-Score6
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 3.15
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.52
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.04
Quick Ratio 0.04
Altman-Z 0.8
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-32.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%648.5%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.1%
Revenue growth 3Y17.71%
Revenue growth 5Y9.23%
Sales Q2Q%-5.36%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-27.66%
EBIT growth 3Y9.06%
EBIT growth 5Y2.14%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y205.14%
FCF growth 3Y63.58%
FCF growth 5Y32.65%
OCF growth 1Y205.14%
OCF growth 3Y63.58%
OCF growth 5Y32.65%